Skip to main content

Table 2 Characteristics of the patients according to D-dimer level

From: Prediction of deep vein thrombosis by ultrasonography and D-dimer in Asian patients with ischemic stroke

 

Abnormal D-dimer

(n = 77)

Normal D-dimer (n = 206)

p-value

Age (years)

68 ± 12

68 ± 11

0.683

Male

50 (64.9%)

122 (59.2%)

0.381

Hypertension

54 (70.1%)

149 (72.3%)

0.715

Diabetes

25 (32.5%)

57 (27.7%)

0.429

Hyperlipidemia

48 (62.3%)

142 (68.9%)

0.293

Smoking

39 (50.6%)

89 (43.2%)

0.263

Previous stroke

12 (15.6%)

31 (15.0%)

.0.911

Peripheral artery disease

30 (39.0%)

77 (37.4%)

0.807

Active cancer

4 (5.2%)

1 (0.5%)

0.007

Deep vein thrombosis

14 (18.2%)

22 (10.7%)

0.092

Stroke mechanism

 Large artery atherosclerosis

18 (23.4%)

60 (29.3%)

0.008

 Small vessel disease

17 (22.1%)

76 (37.1%)

 Cardioembolism

17 (22.1%)

20 (9.8%)

 Other determined

0 (0.0%)

2 (1.0%)

 Undetermined

25 (32.5%)

47 (22.9%)

 BMI (kg/m2)

24 ± 4

24 ± 3

0.665

 mRS before index stroke

0.3 ± 0.8

0.2 ± 0.6

0.218

 Initial NIHSS

5.8 ± 4.5

4.0 ± 3.2

< 0.001

Laboratory results

 AST (mg/dL)

41 ± 4.9

41 ± 5.0

0.941

 ALT (mg/dL)

46 ± 13

43 ± 14

0.106

 BUN (mg/dL)

18 ± 9

17 ± 5

0.414

 Creatinine (mg/dL)

0.9 ± 0.3

0.8 ± 0.4

0.318

 D-dimer (mg/dL)

2.2 ± 2.1

0.3 ± 0.1

< 0.001

 FDP (μg/mL)

10 ± 15

3 ± 2

< 0.001

 Thrombolysis

11 (14.3)

3 (1.5)

< 0.001

Concomitant antithrombotics

 Single antiplatelet

54 (70.1)

166 (80.6)

0.150

 Dual antiplatelet

13 (16.9)

25 (12.1)

 Anticoagulation

10 (13.)

15 (7.3)

  1. DVT Deep vein thrombosis, BMI Body mass index, mRS Modified Rankin scale, NIHSS National Institutes of Health Stroke Scale, AST Aspartate aminotransferase, ALT Alanine aminotransferase, BUN Blood urea nitrogen, FDP Fibrinogen degradation product